Table 1:
Lifetime prevalence of specific phobia in adults according to study and population
| Survey | Sample size | Age range, years | Lifetime prevalence (%) | |||
|---|---|---|---|---|---|---|
| Male participants | Female participants | Total | ||||
| USA and Canada | ||||||
| Bland et al, 198829 | Edmonton | 3258 | ≥18 | 4·6% | 9·8% | 7·2% |
| Eaton et al, 199130 | ECA | 14436 | ≥18 | 7·8% | 14·4% | 11·2% |
| Magee et al, 199631 | NCS | 8098 | 15–54 | 6.7% | 15·7% | 11·3% |
| Kessler et al, 200532 | NCS·R | 9282 | ≥18 | 8·9% | 15·8% | 12·5% |
| Stinson et al, 200723 | NESARC | 43093 | 18–98 | 6·2% | 12·4% | 9·4% |
| Latino populations | ||||||
| Canino et al, 198733 | Puerto Rico | 1551 | 17–64 | 7·6% | 9·6% | 8·6% |
| Vega et al, 199834 | MAPSS | 3012 | 18–59 | 6·2% | 8·8% | 7·4% |
| Vicente et al, 200635 | Chile | 2978 | ≥15 | 4·0% | 14·8% | 9·8% |
| Medina·Mora et al, 200736 | MNCS | 5826 | 18–65 | 7·0% | ||
| Viana and Andrade, 201237 | SPMMHS | 5037 | ≥18 | 7·9% | 16·5% | |
| Europe | ||||||
| Bijl et al, 199838 | NEMESIS | 7076 | 18–64 | 6·6% | 13·6% | 10·1% |
| Kringlen et al, 200139 | Oslo | 2066 | 18–65 | 8·0% | 19·5% | 14·4% |
| Alonso et al, 200440 | ESEMeD | 21 425 | ≥18 | 4·9% | 10·3% | 7·7% |
| Faravelli et al, 200441 | Italy | 2500 | ≥14 | 0·8% | 2·1% | 1·5% |
| Kringlen et al, 200642 | Rural Norway | 1080 | 18–65 | 2.4% | 10·6% | 6·5% |
| de Graaf et al, 201243 | NEMESIS2 | 6646 | 18–64 | 5·5% | 10·3% | 7·9% |
| Kiejna et al, 201544 | Poland | 10 081 | 18–64 | 2·2% | 4·6% | 3·4% |
| Middle East and Africa | ||||||
| Gureje et al, 200645 | Nigeria | 4984 | ≥18 | 5·4% | ||
| Karam et al, 200846 | Lebanon | 2857 | ≥18 | 4·0% | 10·2% | 7·1% |
| Alhasnawi et al, 200947 | Iraq MHS | 4332 | ≥18 | 4·2% | ||
| Asia | ||||||
| Chen et al, 199348 | Hong Kong | 7229 | 18·64 | 0·96% | 3·16% | |
| Oakley Browne et al, 200649 | NZ MHS | 12 992 | ≥16 | 7·3% | 14·1% | 10·8% |
| Lee et al, 200750 | China | 5201 | 18·70 | 2·6% | ||
| Cho et al, 201051 | Korea ECA·R | 6510 | 18·64 | 2·1% | 5·5% | 3·8% |
| Ishikawa et al, 201652 | Japan | 2130 | ≥20 | 3·4% | ||
| Overall* | ||||||
| Median (IQR) | 5·8% (2·4–7·6) | 6.7% (9·2–14·6) | 7·2% (4·0–10·4) | |||
| World MHS26 | ||||||
| 6 low·income and low·middle·income countries | 31 773 | ≥18 | 5·7% | |||
| 6 upper·middle·income countries | 24 612 | ≥18 | 8·0% | |||
| 13 high·income countries | 68 517 | ≥18 | 8·1% | |||
ECA=Epidemiologic Catchment Area. NCS=National Comorbidity Survey. NCS-R=National Comorbidity Survey Replication. NESARC=National Epidemiologic Survey of Alcohol and Related Conditions. MAPSS=Mexican American Prevalence and Services Survey. MNCS=Mexican National Comorbidity Survey. SPMMHS=São Paulo Megacity Mental Health Survey Sample. NEMESIS=Netherlands Mental Health Survey and Incidence Study. ESEMeD=European Study of the Epidemiology of Mental Disorders. MHS=Mental Health Survey. ECA-R=Epidemiologic Catchment Area Replication.
*
Including all studies in table except World MHS.